Study S000710

Phase II Evaluation of Tirzepatide in Adults With Alcohol Use Disorder and Overweight or Obesity

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06994338
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: TRIPLE
Status: RECRUITING
Enrollment: 42
Start: 2025-10-06
Primary completion: 2026-08-31
Lead sponsor: University of Southern California
Conditions: Alcohol Use Disorder; Obesity and Overweight; Alcohol
Interventions: DRUG:Tirzepatide; DRUG:Placebo injections
Results posted: FALSE
Individual participant data sharing: YES
Secondary identifiers: NIH:1R21AA031892-01

Registered primary outcomes

Number of heavy drinking days [Last 4 weeks of treatment (Weeks 5-8)]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.